Literature DB >> 28245761

MicroRNAs as Big Regulators of Neural Stem/Progenitor Cell Proliferation, Differentiation and Migration: A Potential Treatment for Stroke.

Qian Zhang1, Kaiyuan Zhang1, Chao Zhang1, Hongfei Ge1, Yi Yin1, Hua Feng1, Rong Hu1.   

Abstract

BACKGROUND: Neural stem/progenitor cells (NSPCs)-based treatment is a potential therapeutic approach for stroke. MicroRNAs (miRNAs) have been recently verified as promoters or suppressors in the regulation of NSPCs. However, the underlying mechanisms regulating cell biological behaviors of NSPCs remain largely unknown.
METHODS: we retrieved papers focusing on potential roles and mechanisms of miRNAs in the regulation of NSPCs, and paid a special attention to clinical therapeutic potentials of miRNAs in stroke patients. This narrative review provides a comprehensive and critical landscape of this issue.
RESULTS: We summarize the most recent studies on the roles and mechanisms of miRNAs in regulating the proliferation, differentiation and migration of NSPCs and fully discuss the potential clinical implications of miRNAs interacting with NSPCs in stroke patients.
CONCLUSION: Promising but full of hurdles, miRNAs have been confirmed to play a critical role in regulating NSPCs. Clinical potentials of miRNAs are huge in treating stroke patients receiving NSPCs-based therapy, which can be used as biomarkers for the diagnosis and prognosis, and as targets for controlling the proliferation, differentiation and migration of NSPCs. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  differentiation; microRNA; migration; neural stem/progenitor cells; proliferation; stroke

Mesh:

Substances:

Year:  2017        PMID: 28245761     DOI: 10.2174/1381612823666170228124657

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  8 in total

1.  Association of MicroRNAs With Risk of Stroke: A Meta-Analysis.

Authors:  Yidong Deng; Peijian Huang; Fan Zhang; Tao Chen
Journal:  Front Neurol       Date:  2022-05-19       Impact factor: 4.086

2.  Circulating miRNA-3552 as a Potential Biomarker for Ischemic Stroke in Rats.

Authors:  Litao Li; Lipeng Dong; Jingru Zhao; Weiliang He; Bao Chu; Jijie Zhang; Zongkai Wu; Congying Zhao; Jinming Cheng; Wentao Yao; Hebo Wang
Journal:  Biomed Res Int       Date:  2020-07-16       Impact factor: 3.411

3.  Inhibition of miRNA-27b enhances neurogenesis via AMPK activation in a mouse ischemic stroke model.

Authors:  Zhengang Wang; Yimei Yuan; Zhaoguang Zhang; Kuiying Ding
Journal:  FEBS Open Bio       Date:  2019-04-11       Impact factor: 2.693

4.  Upregulation of miR-1269 Contributes to the Progression of Esophageal Squamous Cell Cancer Cells and Is Associated With Poor Prognosis.

Authors:  Xiuhui Bai; Qiang Wang; Xueqi Rui; Xiaohua Li; Xianming Wang
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

5.  MiR-101 Protects Against the Cerebral I/R Injury Through Regulating JAK2/STAT3 Signaling Pathway.

Authors:  Xiaowang Guo; Xiaoyan Shen; Zhijun Yong
Journal:  Neuropsychiatr Dis Treat       Date:  2021-08-24       Impact factor: 2.570

6.  Artesunate promotes the proliferation of neural stem/progenitor cells and alleviates Ischemia-reperfusion Injury through PI3K/Akt/FOXO-3a/p27kip1 signaling pathway.

Authors:  Kaiyuan Zhang; Yang Yang; Hongfei Ge; Ju Wang; Xuezhu Chen; Xuejiao Lei; Jun Zhong; Chao Zhang; Jishu Xian; Yongling Lu; Liang Tan; Hua Feng
Journal:  Aging (Albany NY)       Date:  2020-05-07       Impact factor: 5.682

7.  MicroRNA-125b as a tumor suppressor by targeting MMP11 in breast cancer.

Authors:  Yanan Wang; Yaning Wei; Xiangyu Fan; Pei Zhang; Pan Wang; Shujie Cheng; Jinku Zhang
Journal:  Thorac Cancer       Date:  2020-04-14       Impact factor: 3.500

8.  Prognostic Role of MicroRNA 222 in Patients with Glioma: A Meta-analysis.

Authors:  Yanlin Song; Jing Zhang; Min He; Jianguo Xu
Journal:  Biomed Res Int       Date:  2020-09-25       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.